In a previous study that predominantly was performed for radiopharmacological characterization of a novel EphB4 targeting radioligand in 12 mice no substantial difference in tumor growth between EphB4 and mock transfected A375 tumors was observed [58]. This evidence concerns the gene EPHB4 and neoplasm.